IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer.
IL-4 介导的 TAP2 下调是非小细胞肺癌免疫逃逸和免疫治疗耐药的主要且可逆的机制
期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02276-z
Ranjan Kishu, Rajendran Barani Kumar, Deen Imad Ud, Costantini Adrien, de Rodas Miguel Lopez, Desai Shruti S, Scallo Frankie, Gianino Nicole, Ferrone Soldano, Schalper Kurt A
